Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of daptomycin resistance on Staphylococcus aureus virulence.

Virulence·2015
Same author

Tedizolid: a novel oxazolidinone for Gram-positive infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2013
Same author

Towards squalamine mimics: synthesis and antibacterial activities of head-to-tail dimeric sterol-polyamine conjugates.

Chemistry & biodiversity·2013
Same author

Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus.

The Journal of infectious diseases·2012
Same author

Introduction: Solving the clinical problem of vancomycin resistance.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2012
Same author

Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus.

PloS one·2012
Same journal

Corrigendum to "Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination" [International Journal of Antimicrobial Agents, 57 (2021) 106277].

International journal of antimicrobial agents·2026
Same journal

Ecr positively regulates the activity of the PhoQ/PhoP signaling system in Klebsiella pneumoniae.

International journal of antimicrobial agents·2026
Same journal

Contribution of the Arg-33-His Replacement in the Histidine Kinase CpxA to Carbapenem and Cefiderocol Resistance in Serratia marcescens.

International journal of antimicrobial agents·2026
Same journal

Real world evaluation of HIV-1 reservoir and resistance in virologically suppressed people after 52 weeks of treatment with long-acting cabotegravir + rilpivirine.

International journal of antimicrobial agents·2026
Same journal

Molecular and Epidemiological Characteristics of Cefiderocol-Resistant Klebsiella pneumoniae: A Systematic Review and Genomic Analysis.

International journal of antimicrobial agents·2026
Same journal

Timing and regimen of antiretroviral therapy and all-cause mortality in people with HIV: A time-to-event mediation analysis via opportunistic infection.

International journal of antimicrobial agents·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Discovering new antimicrobial agents.

Robert C Moellering1

  • 1Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. rmoeller@bidmc.harvard.edu

International Journal of Antimicrobial Agents
|November 16, 2010
PubMed
Summary
This summary is machine-generated.

The development of new antimicrobial drugs is declining, but research in academic centers and biotech companies is exploring novel strategies. These include drug potentiators, hybrid agents, and targeting bacterial virulence to combat antimicrobial resistance.

More Related Videos

Isolation of Soil Microorganisms Using iChip Technology
05:33

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on: October 29, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Isolation of Soil Microorganisms Using iChip Technology
05:33

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on: October 29, 2020

Area of Science:

  • Microbiology
  • Pharmacology
  • Drug Discovery

Background:

  • Increasing global antimicrobial resistance poses a significant public health threat.
  • There is a documented decline in the market introduction of new antimicrobial agents over recent decades.
  • Traditional pharmaceutical companies have reduced investment in antimicrobial drug development.

Purpose of the Study:

  • To review the reasons behind the decline in new antimicrobial agent development.
  • To highlight ongoing research and novel strategies for discovering effective antimicrobials.
  • To assess the current state and future prospects of the antimicrobial pipeline.

Main Methods:

  • Analysis of trends in antimicrobial drug development and market introduction.
  • Review of current research methodologies in academic centers and biotechnology companies.
  • Exploration of emerging therapeutic approaches beyond traditional antibiotics.

Main Results:

  • Research efforts have shifted towards academic institutions and small biotechnology firms.
  • Novel strategies include potentiators, hybrid agents, membrane-active drugs, and virulence inhibitors.
  • Exploitation of new bacterial targets, bacteriophages, and lytic enzymes are active areas of investigation.

Conclusions:

  • Despite a challenging pipeline, significant research is underway to discover new antimicrobials.
  • Diverse and innovative approaches are being pursued to address antimicrobial resistance.
  • The future of antimicrobial discovery, while different from the past, remains active and promising.